Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,changeToInventory,changeToNetincome,capitalExpenditures,repurchaseOfStock,changeToAccountReceivables,issuanceOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,marketState,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,exchange,priceHint,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Aug 11, 2003) 4","Short Ratio (Aug 11, 2003) 4","Short % of Float (Aug 11, 2003) 4","Short % of Shares Outstanding (Aug 11, 2003) 4","Shares Short (prior month Jun 09, 2003) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,GTHP,-11768000.0,13278400,16000,,-517000,,-517000,807000,0,-823000,-823000,,-141000,,,,0,0,823000,0,306000,,-517000,-572000,125489000.0,7058000.0,-11768000.0,560000.0,2362000.0,3403000.0,39000.0,-140528000.0,113000.0,-132000.0,18000.0,1247000.0,5990000.0,541000.0,428000.0,1916000.0,24000.0,579000.0,606000.0,2564000.0,49000.0,-1000.0,-557000.0,1386000.0,64000.0,1065000.0,-320000.0,-1000.0,13000.0,-1000.0,,,,-4074000.0,en-US,US,EQUITY,False,Delayed Quote,-3.6370213,0.5299 - 0.59,0.5499,0.0,0.0,0,0,finmb_34654,Other OTC,"Guided Therapeutics, Inc.",USD,10914,2842,0.4449,5.2341175,0.085 - 1.0,-0.4701,-0.4701,0.085,1.0,1553817600,1597867200,1597867200,1597867200,-14400000,False,False,USD,PREPRE,-0.288,-0.893,0.53531426,-0.0054142475,-0.010114147,0.6801956,-0.15029562,-0.2209594,7036224,-0.5933931,15,America/New_York,EDT,GUIDED THERAPEUTICS INC,0.5299,1630519194,-0.01999998,0.59,0.59,0.5299,10192,0,PNK,4,us_market,0.9,,,1.0,0.085,0.5353,0.6802,10.91k,2.84k,13.28M,,6.58M,53.11%,3.77%,,,,0.00%,,,,,,,0.00%,"Mar 28, 2019",,1:800,"Mar 28, 2019","Dec 30, 2020","Mar 30, 2021",0.00%,"-1,600.98%",-74.88%,,102k,0.01,,143k,,-3.69M,-0.2880,,1.25M,0.09,2.54M,,0.32,-0.89,-1.67M,-2.41M,Value,30092,Healthcare,6,"Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.",Norcross,770 242 8723,GA,1609372800,United States,http://www.guidedinc.com,86400,5835 Peachtree Corners East,770 242 8639,Medical Devices,Suite B
t-1,GTHP,-13576000.0,13278400,22000,,2166000,,2166000,351000,85000,-288000,-288000,,-146000,,,,0,25000,313000,-60000,2454000,,2166000,2119000,123109000.0,12205000.0,-13576000.0,244000.0,1350000.0,3403000.0,85000.0,-139956000.0,2228000.0,-132000.0,,182000.0,8962000.0,2287000.0,454000.0,896000.0,24000.0,623000.0,605000.0,2535000.0,-183000.0,-1000.0,-142000.0,-68000.0,460000.0,-399000.0,-331000.0,-478000.0,-2395000.0,-1000.0,-128000.0,-22000.0,,-8066000.0,en-US,US,EQUITY,False,Delayed Quote,-3.6370213,0.5299 - 0.59,0.5499,0.0,0.0,0,0,finmb_34654,Other OTC,"Guided Therapeutics, Inc.",USD,10914,2842,0.4449,5.2341175,0.085 - 1.0,-0.4701,-0.4701,0.085,1.0,1553817600,1597867200,1597867200,1597867200,-14400000,False,False,USD,PREPRE,-0.288,-0.893,0.53531426,-0.0054142475,-0.010114147,0.6801956,-0.15029562,-0.2209594,7036224,-0.5933931,15,America/New_York,EDT,GUIDED THERAPEUTICS INC,0.5299,1630519194,-0.01999998,0.59,0.59,0.5299,10192,0,PNK,4,us_market,0.9,,,1.0,0.085,0.5353,0.6802,10.91k,2.84k,13.28M,,6.58M,53.11%,3.77%,,,,0.00%,,,,,,,0.00%,"Mar 28, 2019",,1:800,"Mar 28, 2019","Dec 30, 2020","Mar 30, 2021",0.00%,"-1,600.98%",-74.88%,,102k,0.01,,143k,,-3.69M,-0.2880,,1.25M,0.09,2.54M,,0.32,-0.89,-1.67M,-2.41M,Value,30092,Healthcare,6,"Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.",Norcross,770 242 8723,GA,1609372800,United States,http://www.guidedinc.com,86400,5835 Peachtree Corners East,770 242 8639,Medical Devices,Suite B
t-2,GTHP,-16441000.0,13278400,41000,,1575000,,1575000,177000,65000,-153000,-153000,,-317000,,,,0,77000,230000,12000,1728000,,1575000,1529000,122362000.0,15120000.0,-16441000.0,213000.0,1300000.0,3404000.0,603000.0,-142075000.0,5551000.0,-132000.0,,581000.0,8305000.0,2378000.0,62000.0,1238000.0,1000.0,1264000.0,53000.0,2725000.0,-267000.0,-1000.0,-262000.0,424000.0,-245000.0,-182000.0,-606000.0,-2000.0,-1794000.0,-1000.0,-128000.0,-1000.0,,-7067000.0,en-US,US,EQUITY,False,Delayed Quote,-3.6370213,0.5299 - 0.59,0.5499,0.0,0.0,0,0,finmb_34654,Other OTC,"Guided Therapeutics, Inc.",USD,10914,2842,0.4449,5.2341175,0.085 - 1.0,-0.4701,-0.4701,0.085,1.0,1553817600,1597867200,1597867200,1597867200,-14400000,False,False,USD,PREPRE,-0.288,-0.893,0.53531426,-0.0054142475,-0.010114147,0.6801956,-0.15029562,-0.2209594,7036224,-0.5933931,15,America/New_York,EDT,GUIDED THERAPEUTICS INC,0.5299,1630519194,-0.01999998,0.59,0.59,0.5299,10192,0,PNK,4,us_market,0.9,,,1.0,0.085,0.5353,0.6802,10.91k,2.84k,13.28M,,6.58M,53.11%,3.77%,,,,0.00%,,,,,,,0.00%,"Mar 28, 2019",,1:800,"Mar 28, 2019","Dec 30, 2020","Mar 30, 2021",0.00%,"-1,600.98%",-74.88%,,102k,0.01,,143k,,-3.69M,-0.2880,,1.25M,0.09,2.54M,,0.32,-0.89,-1.67M,-2.41M,Value,30092,Healthcare,6,"Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.",Norcross,770 242 8723,GA,1609372800,United States,http://www.guidedinc.com,86400,5835 Peachtree Corners East,770 242 8639,Medical Devices,Suite B
t-3,GTHP,-18358000.0,13278400,55000,,-6749000,,-6749000,308000,-6000,-369000,-369000,,-308000,,,,0,0,369000,6000,-6380000,,-6749000,-6766000,121975000.0,17365000.0,-18358000.0,252000.0,942000.0,3403000.0,41000.0,-143604000.0,7576000.0,-132000.0,,763000.0,8630000.0,2569000.0,87000.0,855000.0,,1159000.0,51000.0,2916000.0,86000.0,-1000.0,273000.0,1151000.0,-33000.0,742000.0,-408000.0,6000.0,6136000.0,-1000.0,-128000.0,11000.0,25000.0,-7775000.0,en-US,US,EQUITY,False,Delayed Quote,-3.6370213,0.5299 - 0.59,0.5499,0.0,0.0,0,0,finmb_34654,Other OTC,"Guided Therapeutics, Inc.",USD,10914,2842,0.4449,5.2341175,0.085 - 1.0,-0.4701,-0.4701,0.085,1.0,1553817600,1597867200,1597867200,1597867200,-14400000,False,False,USD,PREPRE,-0.288,-0.893,0.53531426,-0.0054142475,-0.010114147,0.6801956,-0.15029562,-0.2209594,7036224,-0.5933931,15,America/New_York,EDT,GUIDED THERAPEUTICS INC,0.5299,1630519194,-0.01999998,0.59,0.59,0.5299,10192,0,PNK,4,us_market,0.9,,,1.0,0.085,0.5353,0.6802,10.91k,2.84k,13.28M,,6.58M,53.11%,3.77%,,,,0.00%,,,,,,,0.00%,"Mar 28, 2019",,1:800,"Mar 28, 2019","Dec 30, 2020","Mar 30, 2021",0.00%,"-1,600.98%",-74.88%,,102k,0.01,,143k,,-3.69M,-0.2880,,1.25M,0.09,2.54M,,0.32,-0.89,-1.67M,-2.41M,Value,30092,Healthcare,6,"Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.",Norcross,770 242 8723,GA,1609372800,United States,http://www.guidedinc.com,86400,5835 Peachtree Corners East,770 242 8639,Medical Devices,Suite B
